Journal of Thyroid Disorders & Therapy offers the most comprehensive and reliable information pertaining to the latest developments in the field. The Journal also believes in advancing new hypotheses and opinions by means of its high-quality Reviews, Perspectives, and Commentaries. Thus, the content published in the journal is original and comprehensive.

Radioactive iodine therapy (RAIT) is a useful option in the treatment of Graves’ disease; other treatment options include antithyroid drugs (ATDs) and surgery. Endocrinologists select appropriate therapies based on clinical characteristics such as age, thyroid volume, complications, and whether the patient is planning to become pregnant. RAIT does not require hospitalization and can reliably correct hyperthyroidism; however, changes in thyrotropin receptor antibody (TRAb) and thyroid stimulating antibody (TSAb) levels significantly influence the course of pregnancy and the development or exacerbation of Graves' ophthalmopathy.

Journal accepts original manuscripts in the form of research articles, review articles, Clinical reviews, commentaries, case reports, perspectives and short communications encompassing all aspects of related to Thyroid for publication in open access platform. All the manuscript published are available freely online immediately after publication without any subscription charges or registration.

Those who are interested to submit the editorials or their commentaries can submit at https://www.longdom.org/submissions/thyroid-disorders-therapy.htmlor you can mail through this mail id as an attachments  Thyroiddisorders@emedscholar.com

Explore more information at Thyroid Disorders and Therapy. You can share your experiences too by publishing your novel fact findings in this Journal.

Regards
Denise Williams
Editorial Manager     
Journal of Thyroid Disorders & Therapy
E-mail id: Thyroiddisorders@emedscholar.com